Answers are grounded in this paper and cite their sources.
to overexpress the missing enzyme, and infused back into the patient. With this cellular drug vehicle strategy, the brain is populated by improved cells and exposed to supraphysiological levels of the flawed protein, resulting in metabolic correction. This review focuses on the mechanisms of brain repair resulting from HSCT and gene therapy in Inborn Errors of Metabolism. A brief mention will also be made on immune-mediated nervous system diseases that are treated with this approach.
No takes yet. Share an insight, caveat, or question.
Vasconcelos et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: